A head start in Spanish equities

Also available in Spanish, see next article.

First of all, let’s be clear. The following is not investment research/advice.?And, as such, it involves no investment recommendations. These are notes I take to keep myself current on newsflow regarding Spanish equities. I share them freely (and not just as regards price). As always, I am only trying to help. Please read the rest of the “discomplainer (*)” at the end of the article.

Stories in alphabetical order

Banco Sabadell?? (=) 9m23 net profit of €1.028bn +44.9% on NII of €3.512bn +29% (Expansion p17)

Banks sector?(=) The ECB takes a pause and ends 10 consecutive rate rises (Expansion p15)

Catalana Occidente?(=) 9m23 net profit €470.5m +9.3% on revenues of €4.273bn +5.9% (Expansion p18)

Deoleo???(=) Denies being on sale and trusts in lower olive oil prices from June (Expansion p8)

FCC???(=) Mr Carlos Slim will leave FCC close to being taken private with his bid for 7% of shares (Expansion p10)

Fluidra?? (=) Lowers profit by 40% in 9m23 but rises in the market (Expansion p12)

Investment Strategy???(=) The Ibex index falls 0.24% to 8,962, with the ECB taking over from corporate results in the market focus (Expansion p20)

(=) 3Q23 sees a record in public sector employment while that in the private sector is still below that in 2007 (Expansion p26)

Macro?(=) The unemployment rate in the third quarter was 11.84%, with employed workers rising by 209,100 MoM and unemployed by 92,700 (National Statistics Institute)

Naturgy?(=) Chairman calls for “freedom” in order to be able to split his company (Expansion p4)

PharmaMar??(=) Earns 81% less in 9m23 due to the competition to its Yondelis drug (Expansion p12)

Repsol??(-/=) Says that it will take investments abroad if the energy tax continues (Expansion p3)

*The above information has been read/understood/summarised/evaluated/copied as well as I could to provide a guide to Spanish equities (as part of a personal research project on the impact of information transparency on the market i.e. “derecho de cita”), given available timing/intellectual constraints, and I accept no liability for misreading and/or mistranslating the original copy (which I urge you to check, as I am only trying to point you in the right direction, I hope). As for what you may decide to do, after reading the above, please contact your legally approved provider of investment advice on Spanish equities. Feel free to copy (but remember to check the original first).